FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

414008008: Diphtheria/tetanus/pertussis/poliomyelitis/Haemophilus influenzae b vaccine 0.5mL vial (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2690531015 Diphtheria/tetanus/pertussis/poliomyelitis/Haemophilus influenzae b vaccine 0.5mL vial (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2694789015 Diphtheria/tetanus/pertussis/poliomyelitis/Haemophilus influenzae b vaccine 0.5mL vial en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2695551019 Diphtheria / tetanus / pertussis / poliomyelitis / Haemophilus influenzae b vaccine 0.5mL vial en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    4218641000005118 difteri-/tetanus-/kighoste-/polio-/Haemophilus influenzae type B-vaccine hætteglas a 0,5 ml da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    difteri-/tetanus-/kighoste-/polio-/Haemophilus influenzae type B-vaccine hætteglas a 0,5 ml Is a difteri- + tetanus- + kighoste- + polio- + Haemophilus influenzae type b-vaccine false Inferred relationship Some
    difteri-/tetanus-/kighoste-/polio-/Haemophilus influenzae type B-vaccine hætteglas a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. vaccine mod Haemophilus influenzae type B false Inferred relationship Some
    difteri-/tetanus-/kighoste-/polio-/Haemophilus influenzae type B-vaccine hætteglas a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. tetanustoxoid false Inferred relationship Some
    difteri-/tetanus-/kighoste-/polio-/Haemophilus influenzae type B-vaccine hætteglas a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. difterivaccine false Inferred relationship Some
    difteri-/tetanus-/kighoste-/polio-/Haemophilus influenzae type B-vaccine hætteglas a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. levende poliovirusvaccine false Inferred relationship Some
    difteri-/tetanus-/kighoste-/polio-/Haemophilus influenzae type B-vaccine hætteglas a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. kighostevaccine false Inferred relationship Some
    difteri-/tetanus-/kighoste-/polio-/Haemophilus influenzae type B-vaccine hætteglas a 0,5 ml Has manufactured dose form injektionsvæske false Inferred relationship Some
    difteri-/tetanus-/kighoste-/polio-/Haemophilus influenzae type B-vaccine hætteglas a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. inaktiveret poliovirusvaccine false Inferred relationship Some
    difteri-/tetanus-/kighoste-/polio-/Haemophilus influenzae type B-vaccine hætteglas a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Diphtheria vaccine false Inferred relationship Some
    difteri-/tetanus-/kighoste-/polio-/Haemophilus influenzae type B-vaccine hætteglas a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. tetanusvaccine false Inferred relationship Some
    difteri-/tetanus-/kighoste-/polio-/Haemophilus influenzae type B-vaccine hætteglas a 0,5 ml Is a Product manufactured as parenteral dose form (product) false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    Description inactivation indicator reference set

    Back to Start